Literature DB >> 10858345

In vivo increase in resistance to ciprofloxacin in Escherichia coli associated with deletion of the C-terminal part of MarR.

H J Linde1, F Notka, M Metz, B Kochanowski, P Heisig, N Lehn.   

Abstract

We recovered two isolates (EP1 and EP2) of Escherichia coli from the same patient that had identical pulsed-field gel electrophoresis patterns but required different MICs of ciprofloxacin (CIP): 16 and 256 mg/liter for EP1 and EP2, respectively. Both isolates had mutations in the quinolone resistance-determining regions of GyrA (Ser83Leu and Asp87Tyr) and ParC (Ser80Ile), but not in those regions of GyrB or ParE. Isolate EP2 was also more resistant to chloramphenicol, tetracyclines, cefuroxime, and organic solvents. A deletion of adenine (A) 1821 was found in marR of isolate EP2, which resulted in an 18-amino-acid C-terminal deletion in the MarR protein. The causative relationship between DeltaA1821 and the Mar phenotype was demonstrated both by the replacement of the wild-type marR by marR DeltaA1821 in isolate EP1 and by complementation with the wild-type marR in trans in isolate EP2. In isolate EP2 complemented with wild-type marR, susceptibility to chloramphenicol was restored completely, whereas susceptibility to CIP was restored only incompletely. Northern blotting demonstrated increased expression of marA and acrAB but not of soxS in isolate EP2 compared to EP1. In conclusion, the deletion of A1821 in marR in the clinical isolate EP2 caused an increase in the MICs of CIP and unrelated antibiotics. Presumably, the C-terminal part of MarR is necessary for proper repressor function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858345      PMCID: PMC89976          DOI: 10.1128/AAC.44.7.1865-1868.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

Review 1.  The mar regulon: multiple resistance to antibiotics and other toxic chemicals.

Authors:  M N Alekshun; S B Levy
Journal:  Trends Microbiol       Date:  1999-10       Impact factor: 17.079

Review 2.  Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli.

Authors:  P F Miller; M C Sulavik
Journal:  Mol Microbiol       Date:  1996-08       Impact factor: 3.501

3.  Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance.

Authors:  N Lehn; J Stower-Hoffmann; T Kott; C Strassner; H Wagner; M Kronke; W Schneider-Brachert
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.

Authors:  M J Everett; Y F Jin; V Ricci; L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 5.  Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons.

Authors:  V de Lorenzo; K N Timmis
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  A general method for the construction of Escherichia coli mutants by homologous recombination and plasmid segregation.

Authors:  J A Kiel; J P Vossen; G Venema
Journal:  Mol Gen Genet       Date:  1987-05

7.  Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in gram-negative bacteria.

Authors:  M Herrero; V de Lorenzo; K N Timmis
Journal:  J Bacteriol       Date:  1990-11       Impact factor: 3.490

8.  Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.

Authors:  M Oethinger; W V Kern; A S Jellen-Ritter; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

9.  Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.

Authors:  P Heisig
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

10.  Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli.

Authors:  S P Cohen; H Hächler; S B Levy
Journal:  J Bacteriol       Date:  1993-03       Impact factor: 3.490

View more
  11 in total

1.  The periplasmic protein MppA requires an additional mutated locus to repress marA expression in Escherichia coli.

Authors:  Xiaowen Bina; Vincent Perreten; Stuart B Levy
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

2.  N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis.

Authors:  Thulasi Warrier; Kanishk Kapilashrami; Argyrides Argyrou; Thomas R Ioerger; David Little; Kenan C Murphy; Madhumitha Nandakumar; Suna Park; Ben Gold; Jianjie Mi; Tuo Zhang; Eugenia Meiler; Mike Rees; Selin Somersan-Karakaya; Esther Porras-De Francisco; Maria Martinez-Hoyos; Kristin Burns-Huang; Julia Roberts; Yan Ling; Kyu Y Rhee; Alfonso Mendoza-Losana; Minkui Luo; Carl F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

3.  Amino acid residues involved in inactivation of the Escherichia coli multidrug resistance repressor MarR by salicylate, 2,4-dinitrophenol, and plumbagin.

Authors:  Laura M McMurry; Stuart B Levy
Journal:  FEMS Microbiol Lett       Date:  2013-10-21       Impact factor: 2.742

4.  Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.

Authors:  Maria Karczmarczyk; Marta Martins; Teresa Quinn; Nola Leonard; Séamus Fanning
Journal:  Appl Environ Microbiol       Date:  2011-08-19       Impact factor: 4.792

5.  Salicylate increases the expression of marA and reduces in vitro biofilm formation in uropathogenic Escherichia coli by decreasing type 1 fimbriae expression.

Authors:  Jordi Vila; Sara M Soto
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

6.  mar Operon involved in multidrug resistance of Enterobacter aerogenes.

Authors:  Renaud Chollet; Claude Bollet; Jacqueline Chevalier; Monique Malléa; Jean-Marie Pagès; Anne Davin-Regli
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

7.  Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections.

Authors:  Patricia Komp Lindgren; Asa Karlsson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Mutational analysis of the multiple-antibiotic resistance regulator MarR reveals a ligand binding pocket at the interface between the dimerization and DNA binding domains.

Authors:  Valérie Duval; Laura M McMurry; Kimberly Foster; James F Head; Stuart B Levy
Journal:  J Bacteriol       Date:  2013-05-17       Impact factor: 3.490

9.  Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.

Authors:  J M Ling; E W Chan; A W Lam; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

10.  Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.

Authors:  Astrid Pérez; Delia Canle; Cristina Latasa; Margarita Poza; Alejandro Beceiro; María del Mar Tomás; Ana Fernández; Susana Mallo; Sonia Pérez; Francisca Molina; Rosa Villanueva; Iñigo Lasa; Germán Bou
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.